المؤلفون: Grenader T., Pavel M. E., Ruszniewski P. B., Cwikla J. B., Phan A. T., Raderer M., Sedlackova E., Cadiot G., Wolin E. M., Capdevila J., Wall L., Rindi G., Thanh X. -M. T., Caplin M. E., Borbath I., Ysebaert D., Vitek P., Gronbaek H., Adenis A., Buscail L., Dominguez S., Ducreux M., Lombard-Bohas C., Mitry E., Ruszniewski P., Seitz J. F., Begum N., Harsch I., Pavel M., Schofl C., Weber M., Wiedenmann B., Mallath M., Sambasivaiah K., Saxena R., Bajetta E., Buonadonna A., Buzzoni R., Cannizzaro R., Colao A., de Angelis C., Tomassetti P., Cwikla J., Kos-Kudla B., Salek T., Soler G., Tabernero J. M., Ahlman H., Kjellman M., Aithal G., Anthoney A., Grossman A., Newell-Price J., Ramage J., Reed N., Rees A., Steward W., Choti M., CLARINET Study Group

المساهمون: Grenader, T., Pavel, M. E., Ruszniewski, P. B., Cwikla, J. B., Phan, A. T., Raderer, M., Sedlackova, E., Cadiot, G., Wolin, E. M., Capdevila, J., Wall, L., Rindi, G., Thanh, X. -M. T., Caplin, M. E., Borbath, I., Ysebaert, D., Vitek, P., Gronbaek, H., Adenis, A., Buscail, L., Dominguez, S., Ducreux, M., Lombard-Bohas, C., Mitry, E., Ruszniewski, P., Seitz, J. F., Begum, N., Harsch, I., Pavel, M., Schofl, C., Weber, M., Wiedenmann, B., Mallath, M., Sambasivaiah, K., Saxena, R., Bajetta, E., Buonadonna, A., Buzzoni, R., Cannizzaro, R., Colao, A., de Angelis, C., Tomassetti, P., Cwikla, J., Kos-Kudla, B., Salek, T., Soler, G., Tabernero, J. M., Ahlman, H., Kjellman, M., Aithal, G., Anthoney, A., Grossman, A., Newell-Price, J., Ramage, J., Reed, N., Rees, A., Steward, W., Choti, M., CLARINET Study, Group

مصطلحات موضوعية: Lanreotide autogel/depot, Neuroendocrine tumor, Neutrophil/lymphocyte ratio, Prognosi, Progression-free survival, Somatostatin analog

Relation: info:eu-repo/semantics/altIdentifier/pmid/31977567; info:eu-repo/semantics/altIdentifier/wos/WOS:000528817300003; volume:31; issue:3; firstpage:216; lastpage:222; numberofpages:7; journal:ANTI-CANCER DRUGS; https://hdl.handle.net/11368/3056418; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85079344984; https://journals.lww.com/anti-cancerdrugs/fulltext/2020/03000/prognostic_value_of_the_neutrophil_lymphocyte.3.aspx; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028287/

الاتاحة: https://hdl.handle.net/11368/3056418
https://doi.org/10.1097/CAD.0000000000000909
https://journals.lww.com/anti-cancerdrugs/fulltext/2020/03000/prognostic_value_of_the_neutrophil_lymphocyte.3.aspx
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028287/

المؤلفون: Clarisse Dromain, Marianne E. Pavel, Philippe Ruszniewski, Alison Langley, Christine Massien, Eric Baudin, Martyn E. Caplin, on behalf of the CLARINET Study Group

المصدر: BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)

مصطلحات موضوعية: Lanreotide, Neuroendocrine tumor, Prognostic factor, RECIST, Tumor growth rate, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s12885-018-5257-x; https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/1f795cec730848fe9592f8ceb1c701b4

المؤلفون: Dromain, Clarisse, Pavel, Marianne E., Ruszniewski, Philippe, Langley, Alison, Massien, Christine, Baudin, Eric, Caplin, Martyn E., CLARINET Study Group

المصدر: BMC Cancer; 1/14/2019, Vol. 19 Issue 1, p1-9, 9p, 1 Chart, 3 Graphs

مصطلحات موضوعية: INTESTINAL tumors, PANCREATIC tumors, NEUROENDOCRINE tumors, TUMOR growth, ANTINEOPLASTIC agents, METASTASIS, CANCER prognosis, ANTHROPOMETRY, PLACEBOS, PROGNOSIS, STATISTICAL sampling, TUMOR classification, RANDOMIZED controlled trials, TREATMENT effectiveness, PROPORTIONAL hazards models, DISEASE progression, TUMOR grading